Good Friday, July 11, 2025 — Let’s strip away the fluff and get right to why today counts.
Opening Recap
Market Pulse: Stocks drifted after mixed signals on trade and earnings, with energy holding ground as tech underperformed and fresh tariffs out of Washington unsettled the tape.
Key Movers: Delta Air Lines crushed earnings forecasts, Verona Pharma shot up on the Merck tie-up, and Salzgitter found itself in the defense-spending spotlight.
Macro & Politics: A 35% levy on Canadian steel and aluminum rattled U.S. industry, while Europe’s shift toward military contracts put German steelmakers in the limelight.
What’s Next: Keep tabs on any shifts in Ottawa tariff talks and watch for FDA signals on Milestone Pharma’s CARDAMYST™ nasal spray to potentially spark biotech moves.
Unfiltered Market Commentary
Everyone’s focusing on big quarters, but they’re ignoring how tariffs on Canadian metal can creep into manufacturing margins. The buzz is all Delta’s rally and Merck’s deal, yet the real wild card is supply chains getting taxed higher—don’t be surprised if that shows up in next quarter’s guidance. Markets rarely price in policy costs until they bite, and right now that bite could be damn painful if it spreads.
Here’s a thought: Merck’s $10-billion lifeline for its respiratory pipeline and Salzgitter’s defense windfall seem worlds apart, but they’re connected by the same playbook—plug holes with M&A or policy. Whether it’s drug pipelines or steel contracts, corporate lifelines are coming from board rooms and bureaucrats alike. The only thing certain is that smart money will circle where governments hand out guarantee tickets.
Action time: Trim exposure to stretched tech names waiting on tariff clarity and rotate into names that just scored clear catalysts—think Merck-Verona pairs or European defense plays. If you’re not adjusting now, you’ll be chasing the move when these themes go from back pages to front.
📈 Breaking Financial News
Kellogg Megadeal Is This Italian Billionaire's 21st Acquisition – Forbes
Since 2015, Giovanni Ferrero has expanded his family's company beyond brands like Nutella and built a global powerhouse—especially through big acquisitions in the U.S.
50 Best Summer Fashion Deals to Shop on Amazon Prime Day Before It Ends – instyle.com
Amazon Prime Day 2025 is almost over, so shop the 50 best summer fashion deals, including Coach espadrilles, Kate Spade bags, Levi’s jeans, and more. Prices start at just $12.
Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 Stocks Going Wild. Verona Pharma surged by 20.62 percent on Wednesday to end at $104.77 per share following …
Bitcoin hits record high above $116,000 on institutional demand; Dogecoin, Hedera rally up to 12%
Bitcoin hit a record high of $116,893, fueled by institutional investment and optimism surrounding crypto policies under President Trump. Ether also rose, nearing $3,000, while altcoins like Dogecoin and Cardano saw gains. U.S. Bitcoin ETFs have exceeded $50 …
Is This Tiny Town the Key to the AI Revolution?
Loudoun County, Virginia. Population: exploding. Wealth: Concentrated. Secret: A $20 company that's vital to the future of AI. Dylan Jovine's urgent briefing reveals how you can profit.
🔍 Market Analysis & Insights
Walmart recalls 850,000 water bottles after two consumers suffer vision loss from ejecting caps – AP News
Walmart is recalling about 850,000 stainless steel water bottles because the lid can “forcefully eject” and unexpectedly strike consumers — resulting in permanent vision loss for two people to date. The recall covers Walmart’s “Ozark Trail 64 oz Stainless Ste…
Bitcoin Uptrend Intact, But Binance Activity Warns Of Short-Term Pullback
Bitcoin (BTC) reached a new all-time high (ATH) yesterday, climbing to $111,999 on Binance exchange before dipping slightly to around $110,000 at the time of writing. While the broader trend remains bullish, some analysts now anticipate a short-term pullback.…
FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy – STAT
The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment continues.
TRUMP faces crucial test! – A move to $10 will depend on…
TRUMP’s outlook grows uncertain as whale moves, rising inflows, and leverage build pressure.
Amazon's Closing Prime Day With a Secret Luggage Sale — Last-minute Deals From Samsonite, Away, and More Start at $14 – Travel + Leisure
Don’t let Amazon Prime Day pass you by before taking advantage of these can’t-miss luggage sales from Away, Samsonite, Travelpro, and more. Shop the 50 best last-chance Prime Day deals on carry-on bags, checked suitcases, and luggage sets, starting at $15.
$20 = Ounce of Gold?
I've discovered a way to get exposure to MORE than an ounce of gold… for under $20. It's not bullion. It's not ETFs. And it's certainly not crypto. Rather, it's a unique gold play that has outperformed physical gold by 10X over 25 years…
💰 Investment Opportunities
Bitcoin hits new ATH of $118K – Can 2025 take BTC’s price to $150K?
The latest ATH saw a strong demand from institutions as bears got sidelined after a massive liquidation.
Dow futures drop 200 points, S&P set to retreat from record as Trump escalates trade battles: Live updates – CNBC
Investors continued piling into risk assets while shrugging off worries around the latest in trade developments.
Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Market Trends Report
First Bispecific Antibody Drug Conjugates Commercial Approval Expected By 2029 Says Kuick Research First Bispecific Antibody Drug Conjugates Commercial Approval Expected By 2029 Says Kuick Research
Delta shares jump 11% after airline reinstates 2025 profit outlook as CEO says bookings stabilized – CNBC
Delta shares jump 11% after airline reinstates 2025 profit outlook as CEO says bookings stabilizedCNBC Delta grows optimistic as consumer travel reboundsAxios Delta’s Stock Soars Over 10% on Signs of ‘Stabilized’ Travel DemandThe New York Times S&P 500 and Do…
German Steelmaker Salzgitter Thrust Into Defense-Stock Spotlight
A German steelmaker became the latest stock to benefit from a surge in European defense spending this week after getting the go-ahead for one of its products to be used for military purposes.
They're Trying to Cancel Elon Musk, But You Can Profit
The woke mob is targeting Tesla, but savvy investors see a hidden opportunity. A tiny, little-known company is supplying the key technology for Musk's $9 trillion AI revolution. Get in before the mainstream media catches on.